| Specialty | Myeloproliferative Disorders |
|---|---|
| Subspecialty | Hematology - Internal Medicine |
| Clinical Interests | Polycythemia Vera |
| Essential Thrombocythemia | |
| Chronic Myelogenous Leukemia | |
| Primary Myelofibrosis | |
| Languages | English |
| Gender | Male |
| ronald.hoffman@mssm.edu | |
| Education and Training | MD, New York University School of Medicine |
| Residency, Internal Medicine, Montreal General Hospital | |
| Residency, Internal Medicine, Stanford University School of Medicine | |
| Fellowship, Hematology, Mount Sinai Hospital |
| Education and Training | MD, New York University School of Medicine |
|---|---|
| Residency, Internal Medicine, Montreal General Hospital | |
| Residency, Internal Medicine, Stanford University School of Medicine | |
| Fellowship, Hematology, Mount Sinai Hospital | |
| Board Certification | Hematology - Internal Medicine |
| Specialty | Myeloproliferative Disorders |
|---|---|
| Subspecialty | Hematology - Internal Medicine |
| Clinical Interests | Polycythemia Vera |
| Essential Thrombocythemia | |
| Chronic Myelogenous Leukemia | |
| Primary Myelofibrosis | |
| Languages | English |
| Board Certification | Hematology - Internal Medicine |
The Mount Sinai Medical Center is home to an extensive array of top-notch research centers and laboratories, where scientists and researchers work to translate the rapid advances in basic science into the innovative patient care for which we are known.
Participating in Mount Sinai’s clinical trials allows you to take advantage of innovative treatments as we work together to advance the future of medicine.
